GALLMED LTDActive

Company number 08287408Private limited companyIncorporated 2012

Key figures

£73,734+7.8%
Net assets 2023/24
-0.3%
Average annual change 2019/20–2023/24
020 k40 k60 k80 k2019/202020/212021/222022/232023/24

Like most small UK companies, GALLMED LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2023/24
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k2019/202020/212021/222022/232023/24
Filed accounts2019/20–2023/24
2019/202020/212021/222022/232023/24
Cash at bank and in hand2,1751,32836,6463,23312,783
Total assets219,518251,651326,598277,099254,791
Total liabilities144,793174,869282,854——
Net assets / total equity74,72576,78243,74468,40573,734
Average number of employees00044

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: GALLMED LTD

Company

GALLMED LTD is a private limited company registered with Companies House under company number 08287408. It was incorporated on 9 Nov 2012. Its status is active. The registered office is in Uckfield (TN22). Its nature of business (SIC 2007) is manufacture of other food products n.e.c. (10890), wholesale of other food, including fish, crustaceans and molluscs (46380), other retail sale of food in specialised stores (47290), business and domestic software development (62012).

Accounts

The latest accounts in the database are for 2023/24 (period ending 30 Nov 2024); the company files small company accounts (filleted). Net assets were £73,734, up 7.8% on the previous year. Cash at bank and in hand was £12,783. The company had an average of 4 employees. Figures are available for 5 financial years (2019/20–2023/24).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Nov 2026. The next confirmation statement is due by 8 May 2027.